Рынок стартапов
← Все стартапы
Nephrogen

Nephrogen

YCS20

Curative gene therapies for kidney diseases

/ 100
О компании

Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases. Kidney disease affects 1 in 7 Americans (~50 million people), has no cure, and accounts for nearly 10% of the Medicare budget.

Команда
1 чел.
Статус
Active